Topiramate

What is Topiramate?

Topiramate is an anticonvulsant medication, also known as an anti-epileptic drug (AED), that belongs to a class of medications called sulfamate-substituted monosaccharides. Originally developed to treat epilepsy, topiramate has since been approved for migraine prevention and is sometimes prescribed off-label for other conditions. It works by affecting multiple brain pathways to reduce abnormal electrical activity in the nervous system.

Uses

• Epilepsy: Used as monotherapy or adjunctive therapy to control various types of seizures, including partial-onset seizures and primary generalized tonic-clonic seizures in adults and children
• Migraine prevention: FDA-approved for preventing migraine headaches in adults, helping to reduce both frequency and severity of episodes
• Lennox-Gastaut syndrome: Approved for treating seizures associated with this severe form of childhood epilepsy
• Weight management: Combined with phentermine in a prescription weight-loss medication for chronic weight management in obese adults
• Bipolar disorder: Sometimes prescribed off-label as a mood stabilizer, particularly when weight gain from other medications is a concern

How it works

Topiramate has multiple mechanisms of action that contribute to its therapeutic effects. It blocks voltage-dependent sodium channels, enhances the activity of the neurotransmitter GABA, and inhibits certain types of calcium channels, all of which help stabilize nerve cell membranes and reduce excessive electrical activity in the brain. Additionally, it inhibits carbonic anhydrase enzymes, which may contribute to both its neurological effects and some of its side effects.

Side effects

Common side effects:

• Tingling in hands and feet (paresthesias)
• Loss of appetite and weight loss
• Dizziness and fatigue
• Difficulty concentrating and memory problems
• Nausea and taste changes
• Drowsiness
• Speech problems or difficulty finding words
• Nervousness or mood changes

Serious side effects requiring immediate medical attention:

Submit Your Paper

• Sudden vision changes, eye pain, or acute angle-closure glaucoma
• Signs of kidney stones (severe back or side pain, blood in urine)
• Severe mood changes, depression, or suicidal thoughts
• Severe skin reactions or rash
• Signs of metabolic acidosis (rapid breathing, confusion, fatigue)

Warnings and precautions

• Pregnancy: Classified as pregnancy category D; may cause birth defects including cleft lip and palate, and should only be used when benefits outweigh risks
• Kidney function: Dosage adjustments needed in patients with kidney impairment; increased risk of kidney stones, especially in those with a history of nephrolithiasis
• Mental health monitoring: All anticonvulsants carry an FDA warning about increased risk of suicidal thoughts; patients should be monitored for mood changes
• Glaucoma risk: Can cause acute angle-closure glaucoma, particularly in the first month of treatment; patients should seek immediate medical care for eye pain or vision changes
• Heat-related disorders: May cause decreased sweating and increased body temperature, particularly in hot weather or during physical activity

Interactions

• Oral contraceptives: May reduce effectiveness of birth control pills, requiring additional contraceptive methods
• Phenytoin and carbamazepine: These anticonvulsants can decrease topiramate levels, potentially requiring dose adjustments
• Carbonic anhydrase inhibitors: Concurrent use with acetazolamide or other carbonic anhydrase inhibitors increases risk of kidney stones
• CNS depressants: Alcohol and other central nervous system depressants can enhance drowsiness and cognitive effects
• Lithium: Topiramate may increase lithium levels, requiring careful monitoring
• Metformin: May increase metformin concentrations, particularly in patients with kidney impairment
• Valproic acid: Can increase risk of hyperammonemia and encephalopathy when used together
• Digoxin: May decrease digoxin levels, potentially affecting heart rhythm control

Check interactions with the GMJ Interaction Checker

Dosage

Dosage varies significantly based on the condition being treated and individual patient factors. For epilepsy, adults typically start with 25-50 mg daily, gradually increased over several weeks to a maintenance dose of 200-400 mg daily divided into two doses. For migraine prevention, the usual dose ranges from 50-100 mg daily, again starting low and titrating upward. Children’s doses are calculated based on weight and specific indication. Topiramate should be discontinued gradually to prevent breakthrough seizures. All dosing decisions should be made by a healthcare provider who can account for individual medical history, other medications, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).